Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy?

We recently published 10 Most Popular Analyst Calls to Watch This Week. VanEck Pharmaceutical ETF (NASDAQ:PPH) is one of the trending stocks.

Many analysts are picking healthcare stocks as indicators point to a potential rebound in the sector. Karen Finerman, CEO & Co-founder, Metropolitan Capital Advisors, said in a recent program on CNBC that she likes the VanEck Pharmaceutical ETF. Here is what the analyst said:

“VanEck Pharmaceutical ETF (NASDAQ:PPH), this is ETF, big cap pharma. I like it. I think there’s value in this space.”

While we acknowledge the risk and potential of PPH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PPH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.